Cargando…
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
SARS-CoV-2 infection may affect the liver in healthy individuals but also influences the course of COVID-19 in patients with chronic liver disease (CLD). As described in healthy individuals, a strong SARS-CoV-2-specific adaptive immune response is important for the outcome of COVID-19, however, know...
Autores principales: | Luxenburger, Hendrik, Thimme, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423489/ https://www.ncbi.nlm.nih.gov/pubmed/37316169 http://dx.doi.org/10.1136/gutjnl-2023-329623 |
Ejemplares similares
-
Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017) -
Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022) -
Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017) -
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
por: Urban, Stephan, et al.
Publicado: (2021) -
SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
por: Reeg, David B., et al.
Publicado: (2023)